Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Giuseppe Irrera"'
Autor:
Simona Piemontese, Ariane Boumendil, Myriam Labopin, Christoph Schmid, Fabio Ciceri, William Arcese, Yener Koc, Zafar Gulbas, Johanna Tischer, Benedetto Bruno, Depei Wu, Didier Blaise, Dietrich Beelen, Giuseppe Irrera, Annalisa Ruggeri, Mohamed Houhou, Mohamad Mohty, Arnon Nagler, on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background As information on incidence, risk factors, and outcome of acute leukemia (AL) relapse after unmanipulated haploidentical stem cell transplantation (haplo-SCT) is scarce, a retrospective registry study was performed by the Acute Le
Externí odkaz:
https://doaj.org/article/7ec10985c5b14c0890459b8a40c50775
Autor:
Marie Thérèse Rubio, Maud D’Aveni-Piney, Myriam Labopin, Rose-Marie Hamladji, Miguel A. Sanz, Didier Blaise, Hakan Ozdogu, Etienne Daguindeau, Carlos Richard, Stella Santarone, Giuseppe Irrera, Ibrahim Yakoub-Agha, Moshe Yeshurun, Jose L. Diez-Martin, Mohamad Mohty, Bipin N Savani, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2017)
Abstract Background The impact of the use of anti-thymocyte globulin (ATG) in allogeneic stem cell transplantation performed with HLA-identical sibling donors following fludarabine and 4 days intravenous busulfan myeloablative conditioning regimen ha
Externí odkaz:
https://doaj.org/article/ab07e3aad96342e0a5a973957fcae662
Autor:
Roberta Fedele, Massimo Martino, Anna Grazia Recchia, Giuseppe Irrera, Massimo Gentile, Fortunato Morabito
Publikováno v:
Journal of Immunology Research, Vol 2015 (2015)
Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an establi
Externí odkaz:
https://doaj.org/article/276f3b4b62de4940a5aa3bb3d57257f3
Autor:
Arnon Nagler, Myriam Labopin, Norbert-Claude Gorin, Felicetto Ferrara, Miguel A Sanz, Depei Wu, Antonio Torres Gomez, Simona Lapusan, Giuseppe Irrera, Jose E Guimaraes, Aida Botelho Sousa, Angelo M. Carella, Norbert Vey, William Arcese, Avichai Shimoni, Raanan Berger, Vanderson Rocha, Mohamad Mohty
Publikováno v:
Haematologica, Vol 99, Iss 8 (2014)
Oral busulfan is the historical backbone of the busulfan+cyclophosphamide regimen for autologous stem cell transplantation. However intravenous busulfan has more predictable pharmacokinetics and less toxicity than oral busulfan; we, therefore, retros
Externí odkaz:
https://doaj.org/article/4a45c25ccc9040dfb5aa68e1f46cb98a
Autor:
Maria Cuzzola, Maurizio Fiasché, Pasquale Iacopino, Giuseppe Messina, Massimo Martino, Giuseppe Console, Roberta Fedele, Daniela Massi, Anna Grazia Recchia, Giuseppe Irrera, Fortunato Morabito
Publikováno v:
Haematologica, Vol 97, Iss 10 (2012)
Background Acute graft-versus-host disease is a severe complication of allogeneic stem cell transplantation in which the functional immune cells of the donor recognize the recipient as foreign and mount an immunological attack. There is an urgent nee
Externí odkaz:
https://doaj.org/article/39b3d33ab4a04a7b83f50d187fdf2e2f
Autor:
Filippo A. Canale, Massimo Martino, Gaetana Porto, Chiara Verduci, Giuseppe Console, Giuseppe Irrera, Barbara Loteta, Virginia Naso, Marta Pugliese, Tiziana Moscato, Anna Ferreri, Davide Nappi, Fabio Nicolini, Massimiliano Mazza, Giovanni Martinelli, Claudio Cerchione
Publikováno v:
Supportive Care in Cancer. 31
Autor:
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Chiara Verduci, Filippo Antonio Canale, Barbara Loteta, Tiziana Moscato, Caterina Alati, Maria Consuelo Ieracitano, Amelia Cuzzocrea, Maria Altomonte, Maria Teresa Florenzano, Antonella Morabito, Giuseppe Irrera, Virginia Naso, Marta Pugliese, Giuseppe Console, Anna Ferreri, Lucrezia Imbalzano, Giovanni Tripepi, Annalisa Pitino
Publikováno v:
Annals of Hematology.
Autor:
Viviana Loddo, Giuseppe Console, Antonio Maria Rossetti, Massimo Martino, Barbara Loteta, Tiziana Gangemi, Filippo Antonio Canale, Gaetana Porto, Annalisa Paviglianiti, Nicola Meliambro, Anna Ferreri, Marta Pugliese, Letteria Russo, Pasquale Fabio Provenzano, Tiziana Moscato, Domenico Porcino, Antonella Di Costanzo, Virginia Naso, Valentina Romeo, Giuseppe Irrera, Giuseppa Cusumano, Salvatore Gallo
Publikováno v:
Supportive Care in Cancer
Chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent adverse events compromising quality of life (QoL) in patients undergoing autologous stem cell transplantation (ASCT). However, CINV prophylaxis is still lacking uniformity fo
Autor:
Anna, Candoni, Davide, Lazzarotto, Alessandro, Rambaldi, Maria Vittoria, Dubbini, Paola, Bresciani, Alessandro, Busca, William, Arcese, Anna Paola, Iori, Roberto, Sorasio, Giuseppe, Irrera, Renato, Fanin, Fabio, Ciceri, Francesca, Bonifazi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807da96e082cd9acf58ad837e83054e0
http://hdl.handle.net/11390/1221316
http://hdl.handle.net/11390/1221316
Autor:
Virginia Naso, Rosangela Surace, Frank Cirrone, Said Al Sayyad, Bruno Martino, Francesco Curmaci, Giuseppe Scappatura, Renza Monteleone, Giuseppa Cusumano, Demetrio Labate, Barbara Loteta, Maria Pellicano, Vincenzo Amalfi, Filippo Antonio Canale, Domenico Quattrone, Umberto Aguglia, Jessyca Germano, Caterina Stelitano, Viviana Loddo, Antonella Morabito, Giuseppe Console, Letteria Russo, Vittoria Borzumati, Massimo Martino, Antonella Pontari, Antonio Maria Rossetti, Alfonso Trimarchi, Claudio Franzutti, Lucrezia Imbalzano, Giulia Pucci, Sebastiano Macheda, Caterina Alati, Maria Altomonte, Luciano Arcudi, Cristina Sanguedolce, Antonio Moschella, Benedetto Bruno, Vincenzo Dattola, Carmelo Massimiliano Rao, Anna Ferreri, Tiziana Moscato, Caterina Gattuso, Giuseppe Irrera, Maria Teresa Florenzano
Publikováno v:
Expert opinion on biological therapy. 22(3)
INTRODUCTION Chimeric antigen receptor (CAR)-T-cell therapy is a new treatment for patients with hematologic malignancies in which other therapies have failed. AREAS COVERED The review provides an overview for recognizing and managing the most acute